Literature DB >> 19835524

Platelets of type 2 diabetic patients are characterized by high ATP content and low mitochondrial membrane potential.

Xinmin Guo1, Jiajia Wu, Junjun Du, Jianmin Ran, Jie Xu.   

Abstract

Platelet dysfunction plays a critical role in vascular complications of type 2 diabetes mellitus (T2DM). But the relationship between platelet hyperactivity and its energy metabolic process remains unclear. This study was designed to explore alterations of platelet mitochondrial ATP production and the possible mechanism. A total of 39 T2DM patients without macrovascular and microvascular complications and 32 normal controls were fasting sampled. Platelet ATP content was measured by a high performance liquid chromatograph (HPLC). The flow cytometry technique was adopted to evaluate mitochondrial membrane potential (DeltaPsim), the stored force for platelet ATP production. Consequently, T2DM patients exhibited obvious hyperglycemia, hyperlipidemia and hypertension, but normal platelet morphology. Platelet ATP content was significantly higher in T2DM (0.032 +/- 0.010 micromol/10(9) platelets versus 0.017 +/- 0.006 micromol/10(9) platelets, p < 0.001) than in the control group. Interestingly, DeltaPsim was markedly decreased in T2DM patients (0.79 +/- 0.18 versus 2.70 +/- 1.03, p < 0.001) compared with normal controls. For whole subjects, a stepwise regression showed that plasma glycated hemoglobin A1c (HbA1c) level positively correlated to platelet ATP content (beta = 0.552, 95% CI = 0.072-1.451), and fasting plasma glucose (FPG) level was negatively correlated to DeltaPsim (beta = -0.372, 95% CI = -0.471 to -0.089). These data support that hyperglycemia of T2DM promotes platelet mitochondria to generate more ATP, but decreases platelet mitochondrial potential. The discordance between them requires further researches to elucidate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19835524     DOI: 10.3109/09537100903288422

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  20 in total

1.  Inhibition of pyruvate dehydrogenase complex activity by 3-bromopyruvate affects blood platelets responses in type 2 diabetes.

Authors:  Anna Michno; Katarzyna Grużewska; Hanna Bielarczyk; Marlena Zyśk; Andrzej Szutowicz
Journal:  Pharmacol Rep       Date:  2020-01-10       Impact factor: 3.024

2.  Mitochondria in monocytes and macrophages-implications for translational and basic research.

Authors:  Saranya Ravi; Tanecia Mitchell; Philip Kramer; Balu Chacko; Victor M Darley-Usmar
Journal:  Int J Biochem Cell Biol       Date:  2014-05-23       Impact factor: 5.085

3.  Systemic Inflammatory Response Syndrome After Contentious-Flow Left Ventricular Assist Device Implantation and Change in Platelet Mitochondrial Membrane Potential.

Authors:  Nandan K Mondal; Erik N Sorensen; Erika D Feller; Si M Pham; Bartley P Griffith; Zhongjun J Wu
Journal:  J Card Fail       Date:  2015-04-25       Impact factor: 5.712

4.  Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation.

Authors:  Nayra Cardenes; Catherine Corey; Lisa Geary; Shilpa Jain; Sergey Zharikov; Suchitra Barge; Enrico M Novelli; Sruti Shiva
Journal:  Blood       Date:  2014-03-27       Impact factor: 22.113

5.  Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets.

Authors:  Wai Ho Tang; Jeremiah Stitham; Yu Jin; Renjing Liu; Seung Hee Lee; Jing Du; Gourg Atteya; Scott Gleim; Geralyn Spollett; Kathleen Martin; John Hwa
Journal:  Circulation       Date:  2014-01-28       Impact factor: 29.690

6.  Manipulation of the miR-378a/mt-ATP6 regulatory axis rescues ATP synthase in the diabetic heart and offers a novel role for lncRNA Kcnq1ot1.

Authors:  Andrya J Durr; Quincy A Hathaway; Amina Kunovac; Andrew D Taylor; Mark V Pinti; Saira Rizwan; Danielle L Shepherd; Chris C Cook; Garrett K Fink; John M Hollander
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-02       Impact factor: 4.249

7.  Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension.

Authors:  Ruth E McDowell; Kulwant S Aulak; Allaa Almoushref; Celia A Melillo; Brittany E Brauer; Jennie E Newman; Adriano R Tonelli; Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-05       Impact factor: 6.011

Review 8.  Purinergic signalling and diabetes.

Authors:  Geoffrey Burnstock; Ivana Novak
Journal:  Purinergic Signal       Date:  2013-04-03       Impact factor: 3.765

9.  Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood.

Authors:  Balu K Chacko; Philip A Kramer; Saranya Ravi; Michelle S Johnson; Robert W Hardy; Scott W Ballinger; Victor M Darley-Usmar
Journal:  Lab Invest       Date:  2013-03-25       Impact factor: 5.662

10.  Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis.

Authors:  Kakali Ghoshal; Maitree Bhattacharyya
Journal:  ScientificWorldJournal       Date:  2014-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.